First monkeys, and then us? Human cloning must stay off limits
By Marcy Darnovsky,
New Scientist
| 01. 24. 2018
Remember the human cloning controversies of the early 2000s? One reason they faded was that scientists were unable to clone non-human primates. Now that researchers have produced two cloned monkeys, we should brace ourselves for a rerun of arguments in favour of human clones. But human reproductive cloning would be every bit as misguided and dangerous now as it was then.
As long ago as 1971, James Watson of double helix fame warned in The Atlantic about the prospect of “Moving Toward the Clonal Man”. He later changed his mind and began promoting human reproductive cloning, as well as suggesting that human germline modification could tackle stupidity and ensure all women are “pretty”.
In 1997, headlines announced that scientists in the UK had created what had long been considered biologically impossible: a cloned mammal, a sheep dubbed “Dolly”. Debate about creating human clones immediately followed. Time, for example, put Dolly on its cover the following month and posed the question: “Will There Ever Be Another You?”
A few mavericks claimed to be on the verge...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...